Literature DB >> 9288726

Elevation of neuronal expression of NAIP reduces ischemic damage in the rat hippocampus.

D G Xu1, S J Crocker, J P Doucet, M St-Jean, K Tamai, A M Hakim, J E Ikeda, P Liston, C S Thompson, R G Korneluk, A MacKenzie, G S Robertson.   

Abstract

We show here that transient forebrain ischemia selectively elevates levels of neuronal apoptosis inhibitory protein (NAIP) in rat neurons that are resistant to the injurious effects of this treatment. This observation suggests that increasing NAIP levels may confer protection against ischemic cell death. Consistent with this proposal, we demonstrate that two other treatments that increase neuronal NAIP levels, systemic administration of the bacterial alkaloid K252a and intracerebral injection of an adenovirus vector capable of overexpressing NAIP in vivo, reduce ischemic damage in the rat hippocampus. Taken together, these findings suggest that NAIP may play a key role in conferring resistance to ischemic damage and that treatments that elevate neuronal levels of this antiapoptotic protein may have utility in the treatment of stroke.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9288726     DOI: 10.1038/nm0997-997

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  32 in total

1.  Sparing of neuronal function postseizure with gene therapy.

Authors:  J McLaughlin; B Roozendaal; T Dumas; A Gupta; O Ajilore; J Hsieh; D Ho; M Lawrence; J L McGaugh; R Sapolsky
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

2.  Up-regulation of apoptosis inhibitory protein IAP-2 by hypoxia. Hif-1-independent mechanisms.

Authors:  Z Dong; M A Venkatachalam; J Wang; Y Patel; P Saikumar; G L Semenza; T Force; J Nishiyama
Journal:  J Biol Chem       Date:  2001-03-12       Impact factor: 5.157

Review 3.  NF-kappaB in neuronal plasticity and neurodegenerative disorders.

Authors:  M P Mattson; S Camandola
Journal:  J Clin Invest       Date:  2001-02       Impact factor: 14.808

4.  Substrain differences reveal novel disease-modifying gene candidates that alter the clinical course of a rodent model of multiple sclerosis.

Authors:  Leslie E Summers deLuca; Natalia B Pikor; Jennifer O'Leary; Georgina Galicia-Rosas; Lesley A Ward; Dustin Defreitas; Trisha M Finlay; Shalina S Ousman; Lucy R Osborne; Jennifer L Gommerman
Journal:  J Immunol       Date:  2010-02-19       Impact factor: 5.422

5.  Cell-specific DNA fragmentation may be attenuated by a survivin-dependent mechanism after traumatic brain injury in rats.

Authors:  Erik A Johnson; Stanislav I Svetlov; Kevin K W Wang; Ronald L Hayes; Jose A Pineda
Journal:  Exp Brain Res       Date:  2005-10-29       Impact factor: 1.972

Review 6.  Human gene therapy and imaging in neurological diseases.

Authors:  Andreas H Jacobs; Alexandra Winkler; Maria G Castro; Pedro Lowenstein
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-12       Impact factor: 9.236

7.  Secreted frizzled related protein 2 (Sfrp2) is the key Akt-mesenchymal stem cell-released paracrine factor mediating myocardial survival and repair.

Authors:  Maria Mirotsou; Zhongyan Zhang; Arjun Deb; Lunan Zhang; Massimiliano Gnecchi; Nicolas Noiseux; Hui Mu; Alok Pachori; Victor Dzau
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-24       Impact factor: 11.205

Review 8.  Roles for NF-κB and gene targets of NF-κB in synaptic plasticity, memory, and navigation.

Authors:  Wanda M Snow; Brenda M Stoesz; Debbie M Kelly; Benedict C Albensi
Journal:  Mol Neurobiol       Date:  2013-10-13       Impact factor: 5.590

Review 9.  Antioxidant enzyme gene transfer for ischemic diseases.

Authors:  Jian Wu; James G Hecker; Nipavan Chiamvimonvat
Journal:  Adv Drug Deliv Rev       Date:  2009-02-20       Impact factor: 15.470

10.  Fas activation increases neural progenitor cell survival.

Authors:  Julia C Knight; Eugene L Scharf; Yang Mao-Draayer
Journal:  J Neurosci Res       Date:  2010-03       Impact factor: 4.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.